CONICET study suggests that cannabidiol (CBD) may enhance the action of antibiotics in combating resistant bacteria in laboratory tests

Judicial decisions, legislative changes, and inquiries in the European Union keep the sector on hold in the country

Research with elite competitors points to effectiveness in recovery, but warns of risks of accidental doping in CBD use

American research indicates that high-dose cannabidiol could offer relief comparable to traditional analgesics

Study with over 47,000 dogs suggests that continuous use of CBD may reduce aggressive behaviors, bringing new possibilities for animal well-being

Badger G® variety promises to boost the pharmaceutical sector and facilitate monitoring with red leaves and high CBG content

New measures aim to expand access to treatments, train professionals, and adjust adult use rules to combat the informal market

Researchers point to CBD as promising in the treatment of endometriosis, with the potential to reduce pain, inflammation, and associated symptoms, although robust clinical trials are still lacking

FSA public consultation sets next steps for CBD regulation, balancing consumer safety and industry growth

Groundbreaking study shows that vaporized combination of THC and CBD provides fast and lasting relief for migraines, reducing pain, light sensitivity, and sound sensitivity, with few side effects

Cannabidiol-based medication indicated for rare epilepsies, while Infarmed has been evaluating its inclusion in the public health system for almost four years

Interim decision ensures the commercialization of oils and extracts until May 2026 and prevents economic losses to the sector

A study by the University of Yunnan shows that the combination of red light in the vegetative phase and UV-A in flowering increases biomass and raises CBD yield by up to 44% in indoor hemp cultivation

Proposal aims to change rules to allow reimbursement of hemp-derived products in health plans for seniors starting in 2027

Austria eases the sale of CBD flowers until 2028, giving a breath of fresh air to hemp shops after months of uncertainty and legal changes that impacted the sector

Compounds like CBN, CBC, and CBG are gaining prominence in science for their distinct therapeutic properties and role in the entourage effect

Researchers at UNLV have developed synthetic compounds similar to CBD using caraway as a base, showing promising anticonvulsant effects without the use of cannabis

Anvisa has prohibited the manufacturing, sale, and promotion of CBD Brasil's cannabis products due to lack of sanitary authorization

Discover how the safe use of CBD can help patients with Tourette Syndrome reduce impulses and improve quality of life, according to pediatrician Laís Melo on Deusa Cast

New formulations arrive in balanced (1:1) and isolated (300 mg) versions, focusing on quality of life, safety, and treatment customization